These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Negewo NA, McDonald VM, Baines KJ, Wark PA, Simpson JL, Jones PW, Gibson PG. Int J Chron Obstruct Pulmon Dis; 2016 Dec; 11():1495-504. PubMed ID: 27445469 [Abstract] [Full Text] [Related]
7. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease. Katoh S, Ikeda M, Shirai R, Abe M, Ohue Y, Kobashi Y, Oka M. J Asthma; 2018 Oct; 55(10):1052-1058. PubMed ID: 29035604 [Abstract] [Full Text] [Related]
8. Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap. Hiles SA, Gibson PG, McDonald VM. Respirology; 2021 Jan; 26(1):52-61. PubMed ID: 32428971 [Abstract] [Full Text] [Related]
17. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, Sterk PJ. Thorax; 2015 Feb 24; 70(2):115-20. PubMed ID: 25422384 [Abstract] [Full Text] [Related]
18. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. Kang HS, Kim SK, Kim YH, Kim JW, Lee SH, Yoon HK, Rhee CK. BMC Pulm Med; 2021 Mar 02; 21(1):74. PubMed ID: 33653314 [Abstract] [Full Text] [Related]
19. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease. Proboszcz M, Mycroft K, Paplinska-Goryca M, Górska K, Nejman-Gryz P, Jankowski P, Zak N, Krenke R. COPD; 2019 Dec 02; 16(5-6):354-361. PubMed ID: 31631716 [Abstract] [Full Text] [Related]